Discoid lupus erythematosus successfully treated with deucravacitinib.

JAAD Case Rep

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Published: July 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11176598PMC
http://dx.doi.org/10.1016/j.jdcr.2024.04.032DOI Listing

Publication Analysis

Top Keywords

discoid lupus
4
lupus erythematosus
4
erythematosus treated
4
treated deucravacitinib
4
discoid
1
erythematosus
1
treated
1
deucravacitinib
1

Similar Publications

Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report.

SAGE Open Med Case Rep

January 2025

Division of Dermatology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Discoid lupus erythematosus is a chronic, recurring, autoimmune skin disease causing annular, scarring plaques on the head and neck. Deucravacitinib, a tyrosine kinase 2 inhibitor in the Janus kinase inhibitor family, represents an emerging treatment option in systemic lupus erythematosus with potential applicability to discoid lupus erythematosus. We describe a 48-year-old woman with multiple treatment-refractory scalp plaques and associated alopecia treated with deucravacitinib.

View Article and Find Full Text PDF

Nasal Planum Dermatoses of the Dog: Clinical Presentations and Diagnostic Approach.

Vet Clin North Am Small Anim Pract

January 2025

Pathobiology University of Pennsylvania, School of Veterinary Medicine, 3900 Delancey Street, MJR VHUP, Room 4040, Philadelphia, PA 19104, USA.

Nasal planum dermatoses in dogs can be infectious, immune-mediated, allergic, neoplastic, and metabolic in nature. Recognizing key lesions and features and knowing how and when to biopsy can help distinguish between similar diseases. The focus of this article is to review the most commonly encountered nasal planum dermatoses in dogs and to enable the veterinary practitioner to recognize and differentiate between them to obtain a diagnosis.

View Article and Find Full Text PDF

The morphological spectrum of cheilitis.

J Am Acad Dermatol

January 2025

Department of Dermatology and Venereology, AIIMS, Bhubaneswar, India. Pin-751019.

View Article and Find Full Text PDF

Application of Ultraviolet-Induced Fluorescence Trichoscopy (UVFT) in Hair and Scalp Diseases.

Dermatol Ther (Heidelb)

January 2025

Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.

Introduction: Ultraviolet-induced fluorescence dermoscopy (UVFD) is increasingly utilized in dermatooncology and general dermatology. The objective of the study was to characterize the ultraviolet-induced fluorescence trichoscopy (UVFT) findings in a wide range of hair and scalp conditions.

Methods: Consecutive patients with non-scarring alopecias (alopecia areata, AA, n = 40; androgenetic alopecia, AGA, n = 40), scarring alopecias (frontal fibrosing alopecia, FFA, n = 20; lichen planopilaris, LPP, n = 20; folliculitis decalvans, FD, n = 14; discoid lupus erythematosus, DLE, n = 23), and inflammatory scalp conditions (psoriasis, n = 30; seborrheic dermatitis, n = 14) were included.

View Article and Find Full Text PDF

Drug-induced lupus erythematosus (DILE) is an autoimmune reaction that results in symptoms of polyarthralgia, fever, and cutaneous lesions and other manifestations. Several drugs have been documented to cause this disease, including procainamide, isoniazid, methyldopa, penicillamine, and hydralazine. Systemic lupus erythematosus (SLE) manifestations often occur after the patient has been taking the drug without complications for months to years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!